Our Sites

AAA operates in Belgium, Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, UK and U.S. while its distribution network covers more than 30 countries.

Please point to any of the locations to pull up specific details about each facility.

  • Murcia, Spain

    Advanced Accelerator Applications Ibérica S.L.
    Hospital Universitario Virgen de La Arrixaca
    Carretera Madrid – Cartagena S/N
    30120 El Palmar (Murcia)
    Spain

    Tel: +34 968 070 452

    For further information, click here
  • Millburn, United States

    The Millburn facility opened at the end of June 2016. This is our first production and distribution facility in the United States. The 15,000 square foot facility, which is undergoing validation for production of Lutathera, features 12 production lines, as well as storage and office space. This site also serves as a distribution center for NETSPOT™ and Oxygen-18 enriched water, an important precursor for the production of fluorodeoxyglucose used in PET. The site is conveniently located near Newark airport, enabling future delivery of Lutathera directly to hospitals and treatment centers around the country.

    Advanced Accelerator Applications USA, Inc.
    57 East Willow Street
    Millburn, NJ 07041
    USA

    Tel: +1-862-263-0820
    Fax: +1-862-263-0840

    For further information, click here
  • Munich, Germany

    F-18 radiopharmaceutical production site, property of the University Hospital of Munich (Klinikum der Universität München or KUM). AAA is responsible for production and commercialization onsite. The Munich contract includes a long-term F-18 in-house supply agreement with the KUM.

    Advanced Accelerator Applications Germany GmbH
    Im Klinikum der Universität München
    Marchioninistraße 15
    81377 München
    Germany

    For further information, click here
  • Erlangen, Germany

    F-18 radiopharmaceutical production site wholly owned and operated by AAA.

    Advanced Accelerator Applications Germany GmbH
    Am Wetterkreuz 21
    91058 Erlangen
    Germany

    For further information, click here
  • Ravels Weelde, Belgium

    IDB Belgie bvba
    Koningsstraat 35
    2381 Ravels Weelde
    Belgium

    Tel: +32 (0)14 635 170
    Fax: +32 (0)14 828 279

    For further information, click here
  • Boulogne-Billancourt, France

    Advanced Accelerator Applications SA
    19 Rue d’Aguesseau
    92100 Boulogne-Billancourt
    France

    Tel: +33 (0)1 46 08 65 70
    Fax:

    For further information, click here
  • Baarle-Nassau, The Netherlands

    The Baarle-Nassau site hosts the IDB Group which includes IDB Holland bv, IDB Radiopharmacy bv and Beheermaatschappij Welde bv. IDB Holland bv was founded in 1982. IDB produces, markets and sells Lu-177 under the brand name LuMark®, and has established this product as the leading brand of Lutetium 177 worldwide.
    LuMark® is the only Lu-177 product to have received European Marketing Authorization.

    The IDB Group is fully owned by AAA since January 2016.

    IDB Holland bv / IDB Radiopharmacy bv
    Weverstraat 17
    5111 PV Baarle-Nassau
    The Netherlands

    Tel: +31 (0)13 507 95 58
    Fax: +31 (0)13 507 99 12

    For further information, click here
  • Be’er Tuvia, Israel

    The Be’er Tuvia site hosts Marshall Isotopes Ltd., one of only seven suppliers of enriched water — an essential component in the production of radiopharmaceuticals — in the world.

    Marshall was founded in 1998 and acquired by AAA in 2011. The plant is located in the Industrial Zone of Beer-Tuvia, Israel. Regular production of the two standard products,10% and 95% oxygen-18 enriched water started in summer 2000.

    Marshall Isotopes Ltd
    P.O.B. 21154
    Tel-Aviv 61211
    Israel

    Tel: +972-8-8506504
    Fax: +972-8-8506503

    For further information, click here
  • Ottawa, Canada

    Advanced Accelerator Applications Canada, Inc.
    9 Hansen Avenue
    Ottawa, Ontario, K2K 2L9
    Canada

    Tel: +1 (613) 852-3217
    Fax: +1 (613) 212-8990

    For further information, click here
  • Venafro, Italy

    The Venafro site is operational since July 2006. It is AAA’s first Italian laboratory and is located in the industrial zone of Pozzilli-Venafro (Isernia). The laboratory operates in compliance with GMP requirements and produces GLUSCAN®, NaF, [18F]-FMC, [18F]-FMISO and [18F]-FLT.

    Advanced Accelerator Applications Italy, S.r.l.
    Via dell’Industria – Prima Traversa
    86077 Pozzilli (IS)
    Italy

    Tel: +39 0865 91231
    Fax: +39 0865 9123203

     

    For further information, click here
  • Warsaw, Poland

    AAA Polska manufactures and supplies hospitals in Poland with GLUSCAN, and distributes GE Healthcare and Gipharma SPECT products. The Warsaw site started commercial operations in September 2014. Production is GMP certified.

    Advanced Accelerator Applications Polska Sp. z o. o.
    Radiopharmaceuticals Production and Research Centre
    Heavy Ion Laboratory
    Warsaw University
    ul. Pasteura 5A
    02-093 Warszawa
    Poland

    Tel: +48 22 57 21 550
    Fax: +48 22 57 21 551

    For further information, click here
  • Troyes, France

    The Troyes site is operational since September 2008 and is located in the Technopole de l’Aube en Champagne. The laboratory is dedicated to the production of GLUSCAN®, NaF, DOPAVIEW® and PET Investigational Medical Products (IMP).

    Technopole de l’Aube
    14 rue Gustave Eiffel
    10430 Rosières près Troyes
    France

    Tel: +33 (0)3 25 45 14 14
    Fax: +33 (0)3 25 45 14 15

     

    For further information, click here
  • Saragossa, Spain

    The Saragossa site is operational since September 2011. It is located in “La Almunia de Doña Godina” near Saragossa. The laboratory is dedicated to the production of GLUSCAN®.

    Advanced Accelerator Applications Ibérica S.L.
    Poligono Industrial La Cuesta
    50100 La Almunia de Doña Godina
    Spain

    Tel: +34 97 6600 126
    Fax: +34 97 6600 487

    For further information, click here
  • Saluggia, Italy

    The Saluggia site hosts Gipharma, an Italian pharmaceutical contract manufacturer for injectable and freeze dried products, specialized in radiopharmaceuticals for SPECT (Single Photon Emission Computed Tomography).

    Gipharma S.r.l.
    Strada Crescentino
    13040 Saluggia (VC)
    Italy

    Tel: +39 0161 487141
    Fax: +39 0161 487140

     

    For further information, click here
  • Saint-Genis-Pouilly, France

    AAA’s Headquarters are located in Saint-Genis-Pouilly, France. This site is located a few kilometers away from the Swiss border and the Geneva airport.

    The Saint-Genis-Pouilly premises host AAA’s first laboratory (operational since 2003). The laboratory is dedicated to the production and distribution of GLUSCAN®, IASOcholine® and PET Investigational Medical Products (IMP).

    Advanced Accelerator Applications SA
    20 Rue Diesel
    01630 Saint Genis Pouilly
    France

    Tel: +33 (0) 4 50 99 30 70
    Fax: +33 (0) 4 50 99 30 71

    Access Map

    Virtual Tour of Saint Genis site provided by Terabee
    Virtual tour

    For further information, click here
  • Saint-Cloud, France

    The AAA Saint-Cloud site is the fruit of a research collaboration partnership between AAA and the Institut Curie aiming to build, install and operate a pharmaceutical laboratory for the production of radiopharmaceuticals at the Institut Curie’s René Huguenin, a specialist cancer hospital in Saint-Cloud, Paris. The cyclotron guarantees the supply of high quality radiopharmaceuticals for the hospital’s two PET scanners while the Institut Curie evaluates the bioavailability and tumoral affinity of radioactive isotopes labelled with C- 11 and develops new F-18 radiotracers. The AAA Saint-Cloud site supplies hospitals in western France.

    3 rue Charles Lauer
    92210 Saint Cloud
    France

    Tel: +33 (0)1 41 12 07 74
    Fax: +33 (0)1 41 12 03 22

    For further information, click here
  • Lisbon, Portugal

    Advanced Accelerator Applications Portugal Lda.
    Edificio Mar Vermelho
    Av. Dom João II , lote1.06.2.5B
    1998-028 Lisboa
    Portugal

    Tel: +351 211 212 078
    Fax: +351 211 212 100

     

    For further information, click here
  • Porto, Portugal

    Instituto CUF
    Rua da Fonte das Sete Bicas n.º 170
    4460-203 Senhora da Hora
    Matosinhos
    Portugal

    Tel: +351 22 956 38 25/26
    Fax: +351 22 956 38 27

    For further information, click here
  • New York, USA

    AAA’s New York office opened in April 2014. It is located on the 69th floor of the Empire State Building.

    Advanced Accelerator Applications USA, Inc.
    The Empire State Building
    350 5th Avenue, Suite 6902
    New York NY 10118
    USA

    Tel: +1-212-235-2380
    Fax: +1-212-235-2381

    For further information, click here
  • Nantes, France

    The Nantes laboratory is actively involved in the TheraneaM project (THERApy through NEutron Activated Microparticles), for the development of a brachytherapy methodology for the treatment of solid tumours. The laboratory is located in the ARRONAX research center.

    TheraneaM is a collaborative research project that aims to develop an innovative method of treating cancer with sub-micron particles (scale 1/10000 mm), made radioactive in a system driven by a cyclotron and deposited directly in contact with the tumor, using an injection system developed specifically for this application. This technique provides a good tumor targeting by the radioactive substance while sparing surrounding healthy tissue.

    ARRONAX is an important public research center dedicated to the development of innovative radionuclides for research in nuclear medicine and performs research in radiochemistry on radiolysis (study on radiation effects on living or inert matter).

    ARRONAX
    1 rue Aronnax
    44817 Saint Herblain Cedex
    France

    Tel: +33 (0)2 28 21 21 42

    For further information, click here
  • Meldola, Italy

    The Meldola plant is dedicated to the production of PET radiopharmaceuticals and Molecular Probes for the treatment of cancer using Molecular Nuclear Therapy (MNT).

    The Meldola plant has obtained approval from AIFA to produce Lutathera®. Together with our Ivrea laboratory, they are the first industrial pharmaceutical laboratories in the world to receive approval from a central authority to produce an injectable nuclear molecular therapeutic product.

    Advanced Accelerator Applications (Italy), S.r.l.
    Via Piero Maroncelli 40
    47014 Meldola (FC)
    Italy

    Tel: +39 0543 499601
    Fax: +39 0543 499602

    For further information, click here
  • Marseille, France

    The Marseille facility is operational since May 2014. It is both a R&D and a production site. The facility is located in the European Center of Research in Medical imaging (CERIMED), a European center of excellence for the development of molecular imaging technologies.

    Bâtiment CERIMED
    27 boulevard Jean Moulin
    13005 Marseille
    France

    Tel: +33 (0)4 91 16 03 95
    Fax: +33 (0)4 91 16 80 80

     

    For further information, click here
  • Geneva, Switzerland

    The Geneva offices host both AAA International and AAA Switzerland.

    Advanced Accelerator Applications International SA
    4 rue de la Tour de l’île
    1204 Geneva
    Switzerland

    Tel: +41 (0)22 519 0700
    Fax: +41 (0)22 519 0699

    AAA Switzerland is the exclusive distributor of FluoroDeoxyGlucose ([18F]-FDG), from the University Hospital of Geneva (HUG), and [18F]-FMC, produced in the AAA facility in Saint-Genis-Pouilly (France).

    Advanced Accelerator Applications Switzerland SA
    4 rue de la Tour de l’île
    1204 Geneva
    Switzerland

    Tel: +41 (0)22 700 2130
    Fax: +41 (0)22 735 2115

     

    For further information, click here
  • Colleretto Giacosa/Ivrea, Italy

    The Colleretto Giacosa/Ivrea site is operational since July 2007. The laboratory is located in the Bioindustry Park Silvano Fumero near the town of Ivrea (Torino).  The laboratory is mainly dedicated to the production of  GLUSCAN® and Investigational Medical Products (IMP). The facility also produces [18F]-FDOPA, [18F]-FMC, [18F]-NaF, [18F]-FLT, [18F]-FMISO and Lutathera in compliance with GMP requirements.

    The Ivrea plant has obtained approval from AIFA to produce Lutathera. Together with our Meldola laboratory, it is the first industrial pharmaceutical laboratory in the world to receive approval from a central authority to produce an injectable nuclear molecular therapeutic product.

    The laboratory plays an important role in Molecular Imaging for Drug Discovery in collaboration with Ephoran, an AAA-Bracco-BiPCa joint venture. The Ivrea facility is the first industrial pharmaceutical laboratory in the world to produce Molecular Probes for the treatment of cancer using Radio Metabolic Therapy (RMT).

    Advanced Accelerator Applications (Italy), S.r.l.
    Via Ribes, 5
    10010 Colleretto Giacosa (TO)
    Italy

    Tel: +39 0125 561211
    Fax: +39 0125 561202

    For further information, click here
  • Chilcompton, United Kingdom

    The Chilcompton site hosts IEL, a specialist distributor of medical technologies in the UK and Ireland. The company has particular expertise in Nuclear Medicine Pharmaceutical supplies and Radiotherapy Quality Assurance equipment.

    IEL is fully owned by AAA since early 2014.

    Imaging Equipment Ltd
    The Barn, Manor Farm, Church Lane
    Chilcompton, Somerset BA3 4HP
    United Kingdom

    Tel: +44 (0)1761 417 402
    Fax: +44 (0)1761 413 600

    For further information, click here
  • Bonn, Germany

    The Bonn site started commercial operations in September 2014. Production is GMP certified.

    Advanced Accelerator Applications Germany GmbH
    Saime-Genc-Ring 18
    53121 Bonn
    Germany

    Tel: +49 (0)228 925 8830
    Fax: +49 (0)228 925 88320

     

    For further information, click here
  • Béthune, France

    The Béthune site is operational since November 2008. It is located close to the Centre Hospitalier Germon et Gauthier in Béthune. The laboratory is dedicated to the production of GLUSCAN®, IASOcholine® and PET Investigational Medical Products (IMP) such as [18F]-FLT .

    126 Rocade Sud
    62660 Beuvry
    France

    Tel: +33 (0)3 91 82 64 50
    Fax: +33 (0)3 91 82 64 51

     

    For further information, click here
  • Barcelona, Spain

    Advanced Accelerator Applications Ibérica S.L. (Barnatron)
    Carrer Josep Anselm Clavé, 100
    08950 Esplugues de Llobregat
    Spain

    Tel: +34 93 473 51 44
    Fax: +34 93 473 48 39

    Pharmaceutical laboratory for the manufacture of radiopharmaceuticals for diagnostic use in Positron Emission Tomography (PET). Barnatron is part of AAA.

    Advanced Accelerator Applications Ibérica S.L. (offices)
    c/ Anton Fortuny, 14 escalera C, 1º 2ª
    08950 Esplugues de Llobregat
    Spain

    For further information, click here